Effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy versus Brief Eclectic Psychotherapy (BEP) in the treatment of posttraumatic stress disorder.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22337

Enrollment

140

Registered

2005-06-28

Start date

2003-12-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Eye Movement Desensitization and Reprocessing (EMDR) is a combination of trauma exposure (desensitization) with saccadic eye movements. When anxiety diminishes, the patient is instructed to develop mo

Eligibility

Inclusion criteria

Inclusion criteria: 1. Fulfilling diagnostic criteria for PTSD according to the DSM-IV; 2. Having experienced a single traumatic event that was the cause for developing PTSD; 3. Age between 18 and 65 years; 4. Mastery of the Dutch language in speech and writing.

Exclusion criteria

Exclusion criteria: 1. Suicidal ideation; 2. Current severe comorbid disorders that would interfere with the intervention (severe major depressive disorder, severe alcohol or substance dependance); 3. A lifetime psychotic disorder; 4. Indications of fulfilling diagnostic criteria for a personality disorder according to the SCID-II screener and clinical opinion.

Design outcomes

Secondary

Measure	Time frame
Secondary outcomes are clinician-rated PTSD (SI-PTSD), anxiety and depression symptoms (HADS), comorbid psychopathology (SCID-I), quality of life (SF-36), long term costs of illness (TiC-P), posttraumatic cognitions (PTCI), posttraumatic growth (PGI). Tertiary outcomes are the effects of both treatments on neuropsychological functioning (verbal memory and attention) and neuroendocrine parameters of PTSD such as cortisol.	—

Measure

Time frame

Secondary outcomes are clinician-rated PTSD (SI-PTSD), anxiety and depression symptoms (HADS), comorbid psychopathology (SCID-I), quality of life (SF-36), long term costs of illness (TiC-P), posttraumatic cognitions (PTCI), posttraumatic growth (PGI). Tertiary outcomes are the effects of both treatments on neuropsychological functioning (verbal memory and attention) and neuroendocrine parameters of PTSD such as cortisol.

—

Primary

Measure	Time frame
Self-reported PTSD symptoms (Impact of Event Scale –Revised; IES-R).	—

Contacts

Public ContactM.J. Nijdam

Meibergdreef 5, PA3-128

m.j.nijdam@amc.uva.nl+31 (0)20 8913672

Outcome results